Does oxidative stress participate in nerve cell death in Parkinson's disease ?HIRSCH, E. C.European neurology. 1993, Vol 33, pp 52-59, issn 0014-3022, SUP1Conference Paper

The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolismLANNUZEL, A; MICHEL, P. P; HOCQUEMILLER, R et al.Neuroscience. 2003, Vol 121, Num 2, pp 287-296, issn 0306-4522, 10 p.Article

FADD: A link between TNF family receptors and caspases in Parkinson's diseaseHARTMANN, A; MOUATT-PRIGENT, A; FAUCHEUX, B. A et al.Neurology. 2002, Vol 58, Num 2, pp 308-310, issn 0028-3878Article

Glial cells and Parkinson's diseaseHIRSCH, E. C.Journal of neurology. Supplement. 2000, Vol 247, Num 2, pp 58-62, issn 0939-1517Conference Paper

Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian ratsPERIER, C; VILA, M; FEGER, J et al.Experimental neurology (Print). 2000, Vol 162, Num 1, pp 215-224, issn 0014-4886Article

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's diseaseDAMIER, P; HIRSCH, E. C; AGID, Y et al.Brain. 1999, Vol 122, pp 1437-1448, issn 0006-8950, 8Article

[¹²⁵I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeysVILLARES, J; FAUCHEUX, B; HERRERO, M. T et al.Experimental neurology (Print). 1998, Vol 154, Num 1, pp 146-156, issn 0014-4886Article

Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease : an in situ hybridization studyBOISSIERE, F; FAUCHEUX, B; AGID, Y et al.Neuroscience letters. 1997, Vol 221, Num 2-3, pp 141-144, issn 0304-3940Article

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian statesLEVY, R; HAZRATI, L.-N; OBESO, J. A et al.Neuroscience. 1997, Vol 76, Num 2, pp 335-343, issn 0306-4522Article

Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated formTROTTIER, Y; DEVYS, D; IMBERT, G et al.Nature genetics. 1995, Vol 10, Num 1, pp 104-110, issn 1061-4036Article

Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's diseaseANGLADE, P; TSUJI, S; JAVOY-AGID, F et al.Annals of neurology. 1995, Vol 37, Num 2, pp 265-272, issn 0364-5134Article

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseBOKA, G; ANGLADE, P; WALLACH, D et al.Neuroscience letters. 1994, Vol 172, Num 1-2, pp 151-154, issn 0304-3940Article

Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiographyLEHERICY, S; BRANDEL, J.-P; HIRSCH, E. C et al.Brain research. 1994, Vol 659, Num 1-2, pp 1-9, issn 0006-8993Article

Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's diseaseKASTNER, A; HIRSCH, E. C; HERRERO, M. T et al.Journal of neurochemistry. 1993, Vol 61, Num 3, pp 1024-1034, issn 0022-3042Article

Progressive supranuclear palsy : loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formationMALESSA, S; HIRSCH, E. C; CERVERA, P et al.Neurology. 1991, Vol 41, Num 10, pp 1593-1597, issn 0028-3878Article

Nigrostriatal system plasticity in Parkinson's disease : Effect of dopaminergic denervation and treatment. DiscussionHIRSCH, E. C; BENABID; OLANOW et al.Annals of neurology. 2000, Vol 47, Num 4, pp S115-S121, issn 0364-5134, SUP1Article

Blood vessels change in the mesencephalon of patients with Parkinson's diseaseFAUCHEUX, B. A; BONNET, A.-M; AGID, Y et al.Lancet (British edition). 1999, Vol 353, Num 9157, pp 981-982, issn 0140-6736Article

Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal gangliaVILA, M; MARIN, C; RUBERG, M et al.Journal of neurochemistry. 1999, Vol 73, Num 1, pp 344-352, issn 0022-3042Article

Spinocerebellar ataxia type 7 (SCA7) : A neurodegenerative disorder with neuronal intranuclear inclusionsHOLMBERG, M; DUYCKAERTS, C; BRICE, A et al.Human molecular genetics (Print). 1998, Vol 7, Num 5, pp 913-918, issn 0964-6906Article

Iron metabolism and Parkinson's diseaseHIRSCH, E. C; FAUCHEUX, B. A.Movement disorders. 1998, Vol 13, pp 39-45, issn 0885-3185, SUP1Conference Paper

Homéostasie du fer et maladie de Parkinson = Iron homeostasis and Parkinson diseaseFAUCHEUX, B. A; HIRSCH, E. C.Annales de biologie clinique (Paris). 1998, Vol 56, Num JUL, pp 23-30, issn 0003-3898, NSConference Paper

Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's diseaseBOISSIERE, F; FAUCHEUX, B; RUBERG, M et al.Experimental neurology (Print). 1997, Vol 145, Num 1, pp 245-252, issn 0014-4886Article

Effects of L-DOPA-therapy on dopamine D₂ receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeysHERRERO, M. T; AUGOOD, S. J; ASENSI, H et al.Molecular brain research. 1996, Vol 42, Num 1, pp 149-155, issn 0169-328XArticle

Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease : a postmortem study using tritiated tetrabenazineTHIBAUT, F; FAUCHEUX, B. A; MARQUEZ, J et al.Brain research. 1995, Vol 692, Num 1-2, pp 233-243, issn 0006-8993Article

Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal systemKASTNER, A; ANGLADE, P; BOUNAIX, C et al.Neuroscience. 1994, Vol 62, Num 2, pp 449-457, issn 0306-4522Article